We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Brilliant Earth
BRLT
$18M
| $115K | ﹤0.01% |
24,200
-1,300
| -5% | -$8.16K |
|
2377
Blue Owl Capital
OWL
$6.54B
| $113K | ﹤0.01% |
+11,300
| New | +$135K |
|
|
MACK
2378
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $113K | ﹤0.01% |
18,981
-4,200
| -18% | -$23.7K |
|
2379
NextNav
NN
$1.73B
| $111K | ﹤0.01% |
+49,100
| New | +$236K |
|
2380
NatWest
NWG
$72.8B
| $111K | ﹤0.01% |
+18,850
| New | +$113K |
|
2381
Eledon Pharmaceuticals
ELDN
$276M
| $110K | ﹤0.01% |
45,000
-39,011
| -46% | -$119K |
|
|
NEXN
2382
Nexxen International
NEXN
$571M
| $109K | ﹤0.01% |
12,600
-600
| -5% | -$6.87K |
|
|
NEUE
2383
DELISTED
NeueHealth
NEUE
| $109K | ﹤0.01% |
749
+11
| +1% | +$1.6K |
|
|
APLT
2384
DELISTED
Applied Therapeutics
APLT
| $107K | ﹤0.01% |
112,400
+7,300
| +7% | +$12K |
|
|
ATCX
2385
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $107K | ﹤0.01% |
20,300
-23,900
| -54% | -$226K |
|
|
AATC
2386
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $107K | ﹤0.01% |
19,600
-8,100
| -29% | -$48.8K |
|
2387
MeiraGTx Holdings
MGTX
$1.14B
| $105K | ﹤0.01% |
13,900
-1,700
| -11% | -$16.5K |
|
2388
Enviri
NVRI
$620M
| $102K | ﹤0.01% |
+14,400
| New | +$130K |
|
|
HARP
2389
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $102K | ﹤0.01% |
5,340
-5,080
| -49% | -$132K |
|
2390
Cadiz
CDZI
$259M
| $101K | ﹤0.01% |
43,500
-72,300
| -62% | -$151K |
|
2391
Xeris Biopharma Holdings
XERS
$1.42B
| $101K | ﹤0.01% |
65,800
+52,900
| +410% | +$112K |
|
2392
Quantum Corp
QMCO
$432M
| $96K | ﹤0.01% |
3,390
-445
| -12% | -$16.8K |
|
2393
Kodak
KODK
$788M
| $95K | ﹤0.01% |
20,400
+5,500
| +37% | +$28.7K |
|
2394
VirnetX Holding Corp
VHC
$51M
| $95K | ﹤0.01% |
4,061
+3,250
| +401% | +$90.5K |
|
2395
Presidio Property Trust
SQFT
$3.01M
| $94K | ﹤0.01% |
2,960
-1,360
| -31% | -$45.7K |
|
|
LTCH
2396
DELISTED
Latch, Inc. Common Stock
LTCH
| $94K | ﹤0.01% |
+82,300
| New | +$211K |
|
|
FTH
2397
Faeth Therapeutics
FTH
$754M
| $93K | ﹤0.01% |
2,055
+10
| +0.5% | +$375 |
|
|
MAGN
2398
Magnera Corp
MAGN
$490M
| $92K | ﹤0.01% |
+1,031
| New | +$124K |
|
2399
Hippo Holdings
HIPO
$759M
| $89K | ﹤0.01% |
4,060
-2,180
| -35% | -$80.5K |
|
|
CLVS
2400
DELISTED
Clovis Oncology, Inc.
CLVS
| $89K | ﹤0.01% |
49,400
-69,100
| -58% | -$102K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.